# AMVUTTRA

- **Website:** <https://amvuttra.com>
- **Primary alias:** `amvuttra.com`

## Description

AMVUTTRA® (vutrisiran) is a specialized prescription medication developed by Alnylam Pharmaceuticals, aimed at treating polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) in adults. Delivered through an injection every three months by a healthcare professional, AMVUTTRA is the first of its kind designed to provide significant improvements in nerve function and quality of life for patients facing this challenging condition. 

The effectiveness of AMVUTTRA has been validated through various assessments, including the Norfolk Quality of Life-Diabetic Neuropathy (QoL-DN) questionnaire and the mNIS+7 scale, measuring nerve strength and sensation. While it offers hope to over 1,300 patients in the U.S. alone, users should be aware of potential side effects, such as low vitamin A levels and joint pain, necessitating regular consultations with healthcare providers. Alnylam Pharmaceuticals also emphasizes support through their Alnylam Assist program, ensuring patients receive comprehensive information and guidance throughout their treatment journey.

## Industries

- ⛑ Health
- ⛑ Biotechnology and Pharmaceuticals _(under Health)_

## Links

- [facebook](https://facebook.com/AMVUTTRA)
- [instagram](https://instagram.com/amvuttra_vutrisiran)

## Logos & icons

- logo _(primary)_ — PNG, SVG — [download](https://cdn.brandfetch.io/ideExvZAEH/w/820/h/264/theme/dark/logo.png?c=1bxid64Mup7aczewSAYMX&t=1782640171882)

## Colors

| Name | Hex | Theme |
| --- | --- | --- |
| Red Ribbon | #e7004c | accent |
| Black | #000000 | dark |
| Bittersweet | #f87564 | light |

## Fonts

- var(--bs-font-sans-serif) — asset _(custom)_
- GothamBold — asset _(custom)_

---

_Source: <https://brandfetch.com/amvuttra.com>_
_See [/llms.txt](/llms.txt) for a full list of agent-readable pages, and [/auth.md](/auth.md) for how agents authenticate._